| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 130 | 2024 | 1234 | 18.320 |
Why?
|
| Arthroplasty, Replacement, Knee | 91 | 2023 | 1393 | 11.050 |
Why?
|
| Osteoarthritis | 31 | 2024 | 1063 | 6.580 |
Why?
|
| Arthroplasty, Replacement, Hip | 57 | 2023 | 1413 | 6.560 |
Why?
|
| Knee Injuries | 21 | 2023 | 488 | 5.480 |
Why?
|
| Osteoarthritis, Hip | 22 | 2021 | 409 | 4.250 |
Why?
|
| Arthroscopy | 29 | 2024 | 969 | 4.110 |
Why?
|
| Menisci, Tibial | 21 | 2022 | 267 | 3.800 |
Why?
|
| Spinal Stenosis | 11 | 2022 | 261 | 3.740 |
Why?
|
| Musculoskeletal Diseases | 22 | 2024 | 598 | 3.180 |
Why?
|
| Arthralgia | 14 | 2022 | 461 | 3.140 |
Why?
|
| Arthroplasty, Replacement | 13 | 2021 | 310 | 3.060 |
Why?
|
| Knee Joint | 30 | 2023 | 1676 | 3.030 |
Why?
|
| Lumbar Vertebrae | 24 | 2024 | 1879 | 2.890 |
Why?
|
| Zygapophyseal Joint | 9 | 2024 | 128 | 2.850 |
Why?
|
| Exercise Therapy | 11 | 2024 | 929 | 2.650 |
Why?
|
| Occupational Health | 18 | 2024 | 806 | 2.510 |
Why?
|
| Pain Measurement | 45 | 2024 | 3551 | 2.430 |
Why?
|
| Low Back Pain | 16 | 2024 | 984 | 2.390 |
Why?
|
| Upper Extremity | 14 | 2021 | 658 | 2.210 |
Why?
|
| Physical Therapy Modalities | 11 | 2023 | 532 | 2.020 |
Why?
|
| Arthritis, Rheumatoid | 37 | 2022 | 3763 | 1.980 |
Why?
|
| Pain | 40 | 2024 | 5073 | 1.980 |
Why?
|
| Arthritis | 7 | 2019 | 680 | 1.890 |
Why?
|
| Orthopedic Procedures | 9 | 2024 | 1265 | 1.820 |
Why?
|
| Antirheumatic Agents | 22 | 2019 | 1372 | 1.810 |
Why?
|
| Joint Diseases | 9 | 2023 | 459 | 1.710 |
Why?
|
| Injections, Intra-Articular | 8 | 2023 | 280 | 1.700 |
Why?
|
| Rheumatology | 15 | 2022 | 615 | 1.670 |
Why?
|
| Physical Examination | 12 | 2019 | 1255 | 1.590 |
Why?
|
| Pain, Postoperative | 13 | 2024 | 1740 | 1.590 |
Why?
|
| Patient Education as Topic | 11 | 2020 | 2319 | 1.540 |
Why?
|
| Synovitis | 8 | 2023 | 217 | 1.530 |
Why?
|
| Back Pain | 11 | 2024 | 545 | 1.500 |
Why?
|
| Aged | 227 | 2024 | 169310 | 1.500 |
Why?
|
| Medicare | 43 | 2024 | 6770 | 1.490 |
Why?
|
| Humans | 487 | 2024 | 761572 | 1.490 |
Why?
|
| Orthopedics | 13 | 2017 | 898 | 1.400 |
Why?
|
| Male | 311 | 2024 | 360842 | 1.330 |
Why?
|
| Analgesics, Opioid | 17 | 2024 | 3808 | 1.320 |
Why?
|
| Arthroplasty | 4 | 2024 | 313 | 1.290 |
Why?
|
| Female | 318 | 2024 | 392686 | 1.280 |
Why?
|
| Dominican Republic | 10 | 2019 | 76 | 1.280 |
Why?
|
| Middle Aged | 217 | 2024 | 220920 | 1.260 |
Why?
|
| Spinal Neoplasms | 6 | 2021 | 716 | 1.230 |
Why?
|
| Carpal Tunnel Syndrome | 9 | 2014 | 303 | 1.210 |
Why?
|
| Computers | 10 | 2014 | 593 | 1.200 |
Why?
|
| Patient Selection | 13 | 2017 | 4244 | 1.170 |
Why?
|
| Catastrophization | 4 | 2020 | 348 | 1.140 |
Why?
|
| Workplace | 15 | 2024 | 863 | 1.130 |
Why?
|
| Knee Prosthesis | 6 | 2021 | 395 | 1.100 |
Why?
|
| Postoperative Complications | 31 | 2021 | 15633 | 1.100 |
Why?
|
| Knee | 4 | 2023 | 279 | 1.040 |
Why?
|
| Quality-Adjusted Life Years | 12 | 2024 | 1722 | 1.030 |
Why?
|
| Hospitals | 17 | 2018 | 3882 | 1.030 |
Why?
|
| Choice Behavior | 6 | 2011 | 824 | 1.030 |
Why?
|
| Disability Evaluation | 17 | 2024 | 1836 | 1.020 |
Why?
|
| Motor Activity | 6 | 2015 | 2715 | 1.010 |
Why?
|
| Lower Extremity | 6 | 2019 | 1202 | 1.000 |
Why?
|
| Medical History Taking | 3 | 2019 | 774 | 0.980 |
Why?
|
| Health Knowledge, Attitudes, Practice | 12 | 2022 | 4016 | 0.970 |
Why?
|
| Aged, 80 and over | 84 | 2022 | 58986 | 0.950 |
Why?
|
| Patient Satisfaction | 21 | 2017 | 3461 | 0.930 |
Why?
|
| Hospital Bed Capacity | 2 | 2019 | 206 | 0.930 |
Why?
|
| Treatment Outcome | 78 | 2024 | 64684 | 0.930 |
Why?
|
| United States | 97 | 2024 | 72335 | 0.910 |
Why?
|
| Developing Countries | 5 | 2019 | 2885 | 0.900 |
Why?
|
| Radiculopathy | 5 | 2017 | 202 | 0.900 |
Why?
|
| Students | 12 | 2012 | 1741 | 0.890 |
Why?
|
| Universities | 7 | 2014 | 993 | 0.880 |
Why?
|
| Program Evaluation | 8 | 2018 | 2495 | 0.880 |
Why?
|
| Postoperative Care | 4 | 2016 | 1468 | 0.880 |
Why?
|
| Decompression, Surgical | 6 | 2022 | 607 | 0.880 |
Why?
|
| Recovery of Function | 16 | 2024 | 2979 | 0.860 |
Why?
|
| Cost-Benefit Analysis | 29 | 2024 | 5492 | 0.860 |
Why?
|
| Exercise | 10 | 2021 | 5890 | 0.860 |
Why?
|
| Spondylarthritis | 1 | 2024 | 61 | 0.840 |
Why?
|
| Qualitative Research | 12 | 2022 | 3023 | 0.840 |
Why?
|
| Patient Participation | 8 | 2017 | 1445 | 0.830 |
Why?
|
| Health Resources | 4 | 2019 | 935 | 0.830 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2024 | 155 | 0.810 |
Why?
|
| Health Promotion | 11 | 2021 | 2214 | 0.810 |
Why?
|
| Fractures, Spontaneous | 6 | 2019 | 231 | 0.800 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2022 | 10212 | 0.800 |
Why?
|
| Magnetic Resonance Imaging | 34 | 2024 | 36429 | 0.750 |
Why?
|
| Fractures, Stress | 1 | 2023 | 202 | 0.740 |
Why?
|
| Nerve Block | 2 | 2023 | 706 | 0.730 |
Why?
|
| Adult | 132 | 2024 | 221203 | 0.720 |
Why?
|
| Cartilage, Articular | 9 | 2022 | 1099 | 0.720 |
Why?
|
| Osteoporosis | 18 | 2012 | 1606 | 0.720 |
Why?
|
| Health Services Accessibility | 14 | 2020 | 5440 | 0.700 |
Why?
|
| Cohort Studies | 70 | 2022 | 41493 | 0.690 |
Why?
|
| Uveitis | 1 | 2024 | 395 | 0.690 |
Why?
|
| Organizational Culture | 4 | 2019 | 508 | 0.680 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2019 | 45 | 0.670 |
Why?
|
| Spinal Cord Compression | 2 | 2019 | 235 | 0.670 |
Why?
|
| Health Care Costs | 10 | 2024 | 3242 | 0.650 |
Why?
|
| User-Computer Interface | 5 | 2009 | 1400 | 0.650 |
Why?
|
| Comorbidity | 30 | 2019 | 10508 | 0.650 |
Why?
|
| Work | 2 | 2019 | 195 | 0.640 |
Why?
|
| Hospitals, District | 1 | 2019 | 114 | 0.640 |
Why?
|
| Severity of Illness Index | 33 | 2020 | 15843 | 0.640 |
Why?
|
| Bone Diseases | 1 | 2022 | 418 | 0.640 |
Why?
|
| Health Status Indicators | 5 | 2015 | 970 | 0.620 |
Why?
|
| Reoperation | 18 | 2018 | 4303 | 0.610 |
Why?
|
| Ultrasonic Therapy | 1 | 2020 | 215 | 0.610 |
Why?
|
| Practice Guidelines as Topic | 13 | 2019 | 7391 | 0.610 |
Why?
|
| Occupational Diseases | 8 | 2015 | 1490 | 0.610 |
Why?
|
| Perception | 2 | 2017 | 1197 | 0.600 |
Why?
|
| Multivariate Analysis | 23 | 2019 | 12059 | 0.600 |
Why?
|
| Activities of Daily Living | 10 | 2024 | 2421 | 0.600 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 170 | 0.600 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2020 | 159 | 0.600 |
Why?
|
| Prosthesis Failure | 6 | 2015 | 1204 | 0.590 |
Why?
|
| Femoral Fractures | 2 | 2019 | 375 | 0.590 |
Why?
|
| Obesity | 14 | 2024 | 12947 | 0.590 |
Why?
|
| Safety | 2 | 2019 | 1150 | 0.580 |
Why?
|
| Accidental Falls | 5 | 2019 | 1068 | 0.580 |
Why?
|
| Preoperative Care | 8 | 2019 | 2242 | 0.580 |
Why?
|
| Medical Records | 8 | 2013 | 1408 | 0.580 |
Why?
|
| Walking | 4 | 2019 | 1198 | 0.570 |
Why?
|
| Moving and Lifting Patients | 1 | 2017 | 18 | 0.560 |
Why?
|
| Fracture Healing | 1 | 2020 | 445 | 0.560 |
Why?
|
| Cross-Sectional Studies | 40 | 2024 | 26127 | 0.560 |
Why?
|
| Patient Preference | 6 | 2022 | 924 | 0.560 |
Why?
|
| Lifting | 1 | 2017 | 55 | 0.550 |
Why?
|
| Evidence-Based Medicine | 4 | 2019 | 3688 | 0.550 |
Why?
|
| Osteonecrosis | 2 | 2017 | 229 | 0.550 |
Why?
|
| Insurance Claim Reporting | 2 | 2010 | 166 | 0.550 |
Why?
|
| Patient Compliance | 8 | 2018 | 2690 | 0.540 |
Why?
|
| Reproducibility of Results | 33 | 2023 | 20099 | 0.540 |
Why?
|
| Decision Making | 8 | 2022 | 3929 | 0.540 |
Why?
|
| Logistic Models | 24 | 2019 | 13255 | 0.530 |
Why?
|
| Prescription Fees | 1 | 2017 | 153 | 0.520 |
Why?
|
| Age Factors | 31 | 2019 | 18398 | 0.520 |
Why?
|
| Patella | 2 | 2016 | 315 | 0.510 |
Why?
|
| Prevalence | 24 | 2022 | 15732 | 0.510 |
Why?
|
| Acupuncture Therapy | 1 | 2020 | 486 | 0.510 |
Why?
|
| Range of Motion, Articular | 9 | 2019 | 1588 | 0.510 |
Why?
|
| Physician Assistants | 2 | 2015 | 191 | 0.500 |
Why?
|
| Health Services | 7 | 2021 | 752 | 0.490 |
Why?
|
| Osteoarthritis, Spine | 2 | 2011 | 6 | 0.490 |
Why?
|
| Vulnerable Populations | 3 | 2015 | 703 | 0.480 |
Why?
|
| Rheumatic Diseases | 4 | 2008 | 649 | 0.480 |
Why?
|
| Medicare Part A | 2 | 2014 | 40 | 0.480 |
Why?
|
| Leg | 3 | 2013 | 1088 | 0.480 |
Why?
|
| Boston | 15 | 2019 | 9326 | 0.470 |
Why?
|
| Nurse Practitioners | 2 | 2015 | 271 | 0.470 |
Why?
|
| Fractures, Bone | 6 | 2024 | 2046 | 0.470 |
Why?
|
| Buttocks | 3 | 2019 | 111 | 0.470 |
Why?
|
| Shoulder Pain | 5 | 2016 | 151 | 0.470 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2021 | 2273 | 0.460 |
Why?
|
| Osteophyte | 4 | 2022 | 44 | 0.460 |
Why?
|
| Quality Indicators, Health Care | 4 | 2023 | 1792 | 0.450 |
Why?
|
| Translations | 1 | 2014 | 81 | 0.450 |
Why?
|
| Microcomputers | 3 | 2007 | 141 | 0.450 |
Why?
|
| Quality of Life | 21 | 2024 | 13367 | 0.450 |
Why?
|
| Psychometrics | 10 | 2023 | 3065 | 0.450 |
Why?
|
| Spondylolisthesis | 2 | 2022 | 175 | 0.450 |
Why?
|
| Soft Tissue Injuries | 1 | 2015 | 172 | 0.450 |
Why?
|
| Odds Ratio | 16 | 2017 | 9646 | 0.450 |
Why?
|
| Periprosthetic Fractures | 1 | 2014 | 60 | 0.440 |
Why?
|
| Rotator Cuff | 6 | 2017 | 348 | 0.440 |
Why?
|
| Self Report | 12 | 2019 | 3725 | 0.440 |
Why?
|
| Spinal Fractures | 5 | 2019 | 705 | 0.430 |
Why?
|
| Critical Pathways | 2 | 2010 | 474 | 0.430 |
Why?
|
| Multilingualism | 1 | 2014 | 87 | 0.430 |
Why?
|
| Risk Factors | 45 | 2023 | 74213 | 0.430 |
Why?
|
| Algorithms | 6 | 2017 | 14032 | 0.430 |
Why?
|
| Laser Therapy | 1 | 2020 | 1092 | 0.430 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2013 | 92 | 0.420 |
Why?
|
| Consensus | 2 | 2020 | 3123 | 0.420 |
Why?
|
| Postoperative Period | 7 | 2020 | 1814 | 0.420 |
Why?
|
| Neck Pain | 4 | 2013 | 190 | 0.420 |
Why?
|
| Nurse's Role | 1 | 2014 | 188 | 0.420 |
Why?
|
| Intermittent Claudication | 2 | 2017 | 304 | 0.420 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2015 | 787 | 0.420 |
Why?
|
| Drugs, Generic | 1 | 2018 | 448 | 0.410 |
Why?
|
| Health Surveys | 8 | 2016 | 4061 | 0.410 |
Why?
|
| Physicians, Primary Care | 4 | 2019 | 623 | 0.410 |
Why?
|
| Drug Costs | 2 | 2018 | 1183 | 0.410 |
Why?
|
| Cost of Illness | 8 | 2022 | 1936 | 0.410 |
Why?
|
| Sick Leave | 2 | 2021 | 105 | 0.410 |
Why?
|
| Allied Health Personnel | 2 | 2013 | 155 | 0.410 |
Why?
|
| Prospective Studies | 43 | 2022 | 54426 | 0.400 |
Why?
|
| Quality Improvement | 4 | 2017 | 3801 | 0.400 |
Why?
|
| Disabled Persons | 3 | 2017 | 1225 | 0.400 |
Why?
|
| Patient Acceptance of Health Care | 12 | 2018 | 3205 | 0.390 |
Why?
|
| Sensitivity and Specificity | 24 | 2017 | 14666 | 0.390 |
Why?
|
| Preoperative Period | 4 | 2020 | 551 | 0.390 |
Why?
|
| Social Class | 8 | 2015 | 2004 | 0.390 |
Why?
|
| Patient Care Planning | 1 | 2017 | 909 | 0.390 |
Why?
|
| Physicians | 5 | 2022 | 4591 | 0.380 |
Why?
|
| Hip Joint | 4 | 2013 | 1014 | 0.380 |
Why?
|
| Prosthesis Design | 3 | 2018 | 2115 | 0.380 |
Why?
|
| Physician-Patient Relations | 5 | 2016 | 3249 | 0.380 |
Why?
|
| Chronic Disease | 9 | 2019 | 9319 | 0.370 |
Why?
|
| Attitude to Health | 3 | 2011 | 2025 | 0.370 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 992 | 0.370 |
Why?
|
| Posture | 6 | 2014 | 957 | 0.370 |
Why?
|
| Obesity, Morbid | 4 | 2023 | 1277 | 0.370 |
Why?
|
| Arm | 6 | 2013 | 589 | 0.370 |
Why?
|
| Hospitals, Special | 2 | 2008 | 91 | 0.370 |
Why?
|
| Unnecessary Procedures | 1 | 2014 | 415 | 0.360 |
Why?
|
| Transportation of Patients | 1 | 2012 | 174 | 0.360 |
Why?
|
| Therapeutic Equipoise | 1 | 2010 | 28 | 0.360 |
Why?
|
| Health Care Surveys | 7 | 2014 | 2426 | 0.360 |
Why?
|
| Internet | 4 | 2018 | 3093 | 0.360 |
Why?
|
| Disease Progression | 21 | 2022 | 13510 | 0.360 |
Why?
|
| Femoracetabular Impingement | 1 | 2013 | 179 | 0.360 |
Why?
|
| Retrospective Studies | 43 | 2024 | 80646 | 0.360 |
Why?
|
| Cartilage Diseases | 2 | 2021 | 157 | 0.360 |
Why?
|
| Athletic Injuries | 2 | 2019 | 1216 | 0.360 |
Why?
|
| Analgesics | 2 | 2016 | 1070 | 0.360 |
Why?
|
| Refusal to Participate | 2 | 2013 | 31 | 0.350 |
Why?
|
| Computer Simulation | 8 | 2022 | 6241 | 0.350 |
Why?
|
| Self-Assessment | 2 | 2009 | 397 | 0.350 |
Why?
|
| Models, Theoretical | 5 | 2020 | 3575 | 0.350 |
Why?
|
| Disease Management | 3 | 2018 | 2508 | 0.350 |
Why?
|
| Man-Machine Systems | 2 | 2009 | 42 | 0.350 |
Why?
|
| Aorta, Abdominal | 2 | 2012 | 625 | 0.340 |
Why?
|
| Blast Injuries | 1 | 2013 | 322 | 0.340 |
Why?
|
| Hip Dislocation | 2 | 2023 | 247 | 0.340 |
Why?
|
| Biomedical Research | 4 | 2013 | 3429 | 0.330 |
Why?
|
| HIV Infections | 20 | 2016 | 17352 | 0.330 |
Why?
|
| Music Therapy | 1 | 2011 | 110 | 0.330 |
Why?
|
| Telephone | 2 | 2013 | 627 | 0.330 |
Why?
|
| Age Distribution | 10 | 2016 | 2880 | 0.330 |
Why?
|
| Bone Density Conservation Agents | 7 | 2011 | 795 | 0.330 |
Why?
|
| Organizational Policy | 2 | 2017 | 432 | 0.330 |
Why?
|
| Research Design | 13 | 2020 | 6180 | 0.330 |
Why?
|
| Focus Groups | 8 | 2022 | 1413 | 0.330 |
Why?
|
| Adaptation, Psychological | 4 | 2016 | 2629 | 0.320 |
Why?
|
| Laminectomy | 2 | 2021 | 225 | 0.320 |
Why?
|
| Carpometacarpal Joints | 1 | 2009 | 58 | 0.320 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2014 | 464 | 0.320 |
Why?
|
| Edema | 5 | 2024 | 766 | 0.310 |
Why?
|
| Muscular Diseases | 1 | 2013 | 553 | 0.310 |
Why?
|
| Hyaluronic Acid | 2 | 2009 | 483 | 0.310 |
Why?
|
| Socioeconomic Factors | 16 | 2020 | 7827 | 0.310 |
Why?
|
| Spinal Diseases | 3 | 2012 | 564 | 0.310 |
Why?
|
| Body Size | 1 | 2011 | 463 | 0.310 |
Why?
|
| Education, Graduate | 1 | 2009 | 75 | 0.310 |
Why?
|
| Malawi | 2 | 2019 | 304 | 0.310 |
Why?
|
| Education, Distance | 2 | 2022 | 261 | 0.310 |
Why?
|
| Registries | 9 | 2022 | 8224 | 0.300 |
Why?
|
| Time Factors | 28 | 2020 | 39970 | 0.300 |
Why?
|
| Pulmonary Embolism | 4 | 2007 | 2567 | 0.300 |
Why?
|
| Carcinoma | 1 | 2019 | 2330 | 0.300 |
Why?
|
| Quality of Health Care | 8 | 2015 | 4330 | 0.290 |
Why?
|
| Cervical Vertebrae | 3 | 2012 | 980 | 0.290 |
Why?
|
| AIDS Serodiagnosis | 4 | 2013 | 220 | 0.290 |
Why?
|
| Shoulder Joint | 4 | 2014 | 742 | 0.290 |
Why?
|
| Injections, Intramuscular | 2 | 2018 | 554 | 0.280 |
Why?
|
| Follow-Up Studies | 23 | 2021 | 39107 | 0.280 |
Why?
|
| Paralysis | 2 | 2018 | 250 | 0.280 |
Why?
|
| Spinal Fusion | 4 | 2022 | 1286 | 0.280 |
Why?
|
| Young Adult | 30 | 2020 | 59255 | 0.280 |
Why?
|
| Industry | 2 | 2017 | 364 | 0.280 |
Why?
|
| Referral and Consultation | 4 | 2012 | 3600 | 0.280 |
Why?
|
| Femoral Neck Fractures | 1 | 2008 | 142 | 0.280 |
Why?
|
| Poisson Distribution | 2 | 2019 | 504 | 0.270 |
Why?
|
| Predictive Value of Tests | 17 | 2020 | 15266 | 0.270 |
Why?
|
| Metacarpophalangeal Joint | 2 | 2008 | 82 | 0.270 |
Why?
|
| Shoulder Impingement Syndrome | 3 | 2013 | 35 | 0.270 |
Why?
|
| Carpal Joints | 1 | 2006 | 11 | 0.270 |
Why?
|
| Diagnosis-Related Groups | 1 | 2008 | 449 | 0.270 |
Why?
|
| Linear Models | 8 | 2017 | 5872 | 0.270 |
Why?
|
| Diaphyses | 2 | 2019 | 65 | 0.260 |
Why?
|
| Arthritis, Psoriatic | 1 | 2009 | 219 | 0.260 |
Why?
|
| Cumulative Trauma Disorders | 2 | 2012 | 151 | 0.260 |
Why?
|
| Awards and Prizes | 2 | 2007 | 360 | 0.260 |
Why?
|
| Tramadol | 2 | 2016 | 60 | 0.260 |
Why?
|
| Models, Economic | 4 | 2019 | 716 | 0.260 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2008 | 237 | 0.260 |
Why?
|
| Hospitalization | 7 | 2014 | 10721 | 0.250 |
Why?
|
| Glucocorticoids | 7 | 2022 | 2161 | 0.250 |
Why?
|
| Intention to Treat Analysis | 2 | 2019 | 413 | 0.250 |
Why?
|
| Metacarpal Bones | 1 | 2006 | 75 | 0.250 |
Why?
|
| Hypertension | 4 | 2017 | 8540 | 0.250 |
Why?
|
| Incidence | 18 | 2022 | 21355 | 0.250 |
Why?
|
| Longevity | 1 | 2013 | 1065 | 0.250 |
Why?
|
| Pennsylvania | 13 | 2011 | 613 | 0.250 |
Why?
|
| Reward | 3 | 2018 | 971 | 0.250 |
Why?
|
| Data Interpretation, Statistical | 5 | 2021 | 2691 | 0.250 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2021 | 1881 | 0.250 |
Why?
|
| Bandages | 1 | 2007 | 269 | 0.250 |
Why?
|
| Workload | 3 | 2013 | 844 | 0.250 |
Why?
|
| Joints | 1 | 2007 | 322 | 0.250 |
Why?
|
| Guideline Adherence | 5 | 2018 | 2220 | 0.250 |
Why?
|
| South Africa | 13 | 2016 | 1843 | 0.240 |
Why?
|
| Primary Health Care | 4 | 2020 | 4686 | 0.240 |
Why?
|
| Overweight | 6 | 2024 | 2417 | 0.240 |
Why?
|
| Observation | 1 | 2007 | 310 | 0.240 |
Why?
|
| Leptin | 2 | 2012 | 1597 | 0.240 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4948 | 0.240 |
Why?
|
| Massachusetts | 11 | 2021 | 8830 | 0.240 |
Why?
|
| Clinical Competence | 4 | 2016 | 4793 | 0.240 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1852 | 0.240 |
Why?
|
| Weight Loss | 6 | 2024 | 2684 | 0.230 |
Why?
|
| Treatment Failure | 4 | 2019 | 2644 | 0.230 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2016 | 832 | 0.230 |
Why?
|
| Delphi Technique | 4 | 2020 | 846 | 0.230 |
Why?
|
| Employment | 2 | 2015 | 1118 | 0.230 |
Why?
|
| Decision Support Techniques | 4 | 2015 | 1998 | 0.230 |
Why?
|
| Gastric Bypass | 2 | 2023 | 818 | 0.230 |
Why?
|
| Risk Assessment | 15 | 2019 | 23996 | 0.230 |
Why?
|
| Physician's Role | 2 | 2011 | 917 | 0.230 |
Why?
|
| Lumbosacral Region | 2 | 2023 | 293 | 0.230 |
Why?
|
| Health Status | 9 | 2018 | 4077 | 0.230 |
Why?
|
| Anticoagulants | 5 | 2020 | 4812 | 0.220 |
Why?
|
| Confidence Intervals | 7 | 2010 | 2927 | 0.220 |
Why?
|
| Medication Adherence | 2 | 2014 | 2176 | 0.220 |
Why?
|
| Muscle Strength | 3 | 2018 | 624 | 0.220 |
Why?
|
| Sex Factors | 13 | 2016 | 10553 | 0.220 |
Why?
|
| Fibromyalgia | 2 | 2008 | 405 | 0.220 |
Why?
|
| Radiography | 11 | 2017 | 6965 | 0.220 |
Why?
|
| Mental Health | 2 | 2015 | 3250 | 0.220 |
Why?
|
| Mortality | 3 | 2019 | 2901 | 0.220 |
Why?
|
| Back Injuries | 2 | 2007 | 41 | 0.220 |
Why?
|
| Professional Competence | 1 | 2007 | 431 | 0.220 |
Why?
|
| Program Development | 3 | 2016 | 1297 | 0.220 |
Why?
|
| Mass Screening | 13 | 2019 | 5428 | 0.220 |
Why?
|
| Outpatients | 2 | 2014 | 1597 | 0.220 |
Why?
|
| Observer Variation | 6 | 2016 | 2606 | 0.220 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 2206 | 0.220 |
Why?
|
| Health Services Research | 3 | 2015 | 1812 | 0.220 |
Why?
|
| Leisure Activities | 2 | 2015 | 308 | 0.220 |
Why?
|
| Life Expectancy | 2 | 2011 | 1242 | 0.210 |
Why?
|
| Adolescent | 26 | 2020 | 88324 | 0.210 |
Why?
|
| Delayed Diagnosis | 2 | 2024 | 463 | 0.210 |
Why?
|
| Residence Characteristics | 4 | 2012 | 2094 | 0.210 |
Why?
|
| Ambulatory Care | 3 | 2009 | 2775 | 0.210 |
Why?
|
| Neurologic Examination | 3 | 2017 | 916 | 0.210 |
Why?
|
| Forms and Records Control | 1 | 2003 | 158 | 0.210 |
Why?
|
| Drug Prescriptions | 3 | 2022 | 1670 | 0.210 |
Why?
|
| Sex Distribution | 6 | 2016 | 2281 | 0.200 |
Why?
|
| Clinical Trials as Topic | 5 | 2015 | 8002 | 0.200 |
Why?
|
| Fracture Fixation, Internal | 2 | 2008 | 973 | 0.200 |
Why?
|
| Hemodynamics | 1 | 2013 | 4160 | 0.200 |
Why?
|
| Self Care | 1 | 2007 | 796 | 0.200 |
Why?
|
| Nursing Homes | 4 | 2024 | 1082 | 0.200 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 1303 | 0.200 |
Why?
|
| Insurance | 1 | 2023 | 113 | 0.200 |
Why?
|
| Bicycling | 1 | 2003 | 177 | 0.200 |
Why?
|
| Patient-Centered Care | 2 | 2014 | 1421 | 0.200 |
Why?
|
| Body Mass Index | 10 | 2024 | 12954 | 0.190 |
Why?
|
| Finger Joint | 3 | 2013 | 108 | 0.190 |
Why?
|
| Safety Management | 2 | 2018 | 760 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2016 | 20571 | 0.190 |
Why?
|
| Motivation | 4 | 2019 | 2006 | 0.190 |
Why?
|
| Patient Care | 1 | 2007 | 622 | 0.190 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2016 | 384 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2021 | 1390 | 0.190 |
Why?
|
| Hip Prosthesis | 2 | 2021 | 921 | 0.190 |
Why?
|
| Orthotic Devices | 3 | 2011 | 129 | 0.190 |
Why?
|
| Accidents, Occupational | 3 | 2014 | 249 | 0.190 |
Why?
|
| Educational Status | 5 | 2015 | 2522 | 0.190 |
Why?
|
| Quality Assurance, Health Care | 3 | 2011 | 2169 | 0.180 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 299 | 0.180 |
Why?
|
| Interviews as Topic | 7 | 2021 | 2696 | 0.180 |
Why?
|
| Pilot Projects | 9 | 2016 | 8633 | 0.180 |
Why?
|
| Oxycodone | 3 | 2017 | 139 | 0.180 |
Why?
|
| Inflammation | 4 | 2024 | 10773 | 0.180 |
Why?
|
| Data Collection | 6 | 2013 | 3322 | 0.180 |
Why?
|
| Esthetics | 1 | 2002 | 330 | 0.180 |
Why?
|
| Hand | 4 | 2021 | 903 | 0.180 |
Why?
|
| Joint Prosthesis | 2 | 2014 | 253 | 0.180 |
Why?
|
| Synovial Fluid | 1 | 2023 | 393 | 0.180 |
Why?
|
| Venous Thromboembolism | 4 | 2019 | 1866 | 0.180 |
Why?
|
| Case-Control Studies | 12 | 2024 | 22176 | 0.180 |
Why?
|
| Demography | 4 | 2017 | 1648 | 0.180 |
Why?
|
| Prognosis | 11 | 2019 | 29629 | 0.180 |
Why?
|
| Neural Conduction | 1 | 2002 | 441 | 0.180 |
Why?
|
| Mobility Limitation | 2 | 2018 | 408 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13382 | 0.180 |
Why?
|
| Spine | 1 | 2007 | 1118 | 0.180 |
Why?
|
| Proportional Hazards Models | 12 | 2019 | 12463 | 0.180 |
Why?
|
| Health Personnel | 4 | 2020 | 3335 | 0.180 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 3530 | 0.170 |
Why?
|
| Concept Formation | 1 | 2021 | 161 | 0.170 |
Why?
|
| Bone Marrow Diseases | 2 | 2016 | 233 | 0.170 |
Why?
|
| Blood Platelets | 1 | 2011 | 2479 | 0.170 |
Why?
|
| Patient Care Team | 3 | 2021 | 2521 | 0.170 |
Why?
|
| Minority Groups | 4 | 2020 | 1203 | 0.170 |
Why?
|
| Southwestern United States | 2 | 2012 | 39 | 0.170 |
Why?
|
| Task Performance and Analysis | 2 | 2014 | 763 | 0.170 |
Why?
|
| Hip Fractures | 4 | 2014 | 988 | 0.170 |
Why?
|
| Sciatica | 3 | 2017 | 97 | 0.170 |
Why?
|
| Spinal Nerve Roots | 2 | 2011 | 121 | 0.170 |
Why?
|
| Databases, Factual | 9 | 2022 | 7967 | 0.170 |
Why?
|
| First Aid | 1 | 2019 | 69 | 0.170 |
Why?
|
| Family Practice | 1 | 2002 | 512 | 0.170 |
Why?
|
| Efficiency | 2 | 2019 | 476 | 0.170 |
Why?
|
| Osteoporotic Fractures | 3 | 2014 | 411 | 0.160 |
Why?
|
| Communicable Diseases | 1 | 2008 | 875 | 0.160 |
Why?
|
| Health Policy | 1 | 2012 | 2684 | 0.160 |
Why?
|
| Competitive Behavior | 1 | 2019 | 78 | 0.160 |
Why?
|
| Depression | 4 | 2022 | 8124 | 0.160 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 1386 | 0.160 |
Why?
|
| Musculoskeletal Manipulations | 1 | 2018 | 24 | 0.160 |
Why?
|
| Mobile Health Units | 1 | 2020 | 92 | 0.160 |
Why?
|
| Ownership | 1 | 2021 | 339 | 0.160 |
Why?
|
| Health Behavior | 2 | 2012 | 2644 | 0.160 |
Why?
|
| Leukocyte Count | 1 | 2023 | 1596 | 0.160 |
Why?
|
| Pharmaceutical Services | 1 | 2020 | 141 | 0.160 |
Why?
|
| Bone Nails | 1 | 2020 | 220 | 0.160 |
Why?
|
| HIV Seropositivity | 3 | 2013 | 960 | 0.160 |
Why?
|
| Ohio | 3 | 2024 | 322 | 0.160 |
Why?
|
| Pharmacy | 1 | 2020 | 91 | 0.160 |
Why?
|
| Smoking | 1 | 2015 | 9053 | 0.160 |
Why?
|
| Longitudinal Studies | 14 | 2022 | 14607 | 0.160 |
Why?
|
| Neuralgia | 2 | 2022 | 615 | 0.150 |
Why?
|
| Warfarin | 1 | 2007 | 1483 | 0.150 |
Why?
|
| Single-Blind Method | 3 | 2012 | 1574 | 0.150 |
Why?
|
| Counseling | 4 | 2015 | 1547 | 0.150 |
Why?
|
| After-Hours Care | 1 | 2019 | 102 | 0.150 |
Why?
|
| Likelihood Functions | 3 | 2017 | 992 | 0.150 |
Why?
|
| Automobile Driving | 2 | 2014 | 441 | 0.150 |
Why?
|
| Critical Illness | 1 | 2011 | 2723 | 0.150 |
Why?
|
| Arthrodesis | 1 | 2019 | 186 | 0.150 |
Why?
|
| Healthcare Disparities | 4 | 2018 | 3358 | 0.150 |
Why?
|
| Personal Satisfaction | 2 | 2022 | 644 | 0.150 |
Why?
|
| Selection Bias | 2 | 2010 | 359 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 2720 | 0.140 |
Why?
|
| Surgical Wound Infection | 2 | 2007 | 1529 | 0.140 |
Why?
|
| Academic Medical Centers | 4 | 2016 | 2759 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 778 | 0.140 |
Why?
|
| Pain Threshold | 1 | 2021 | 604 | 0.140 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2010 | 396 | 0.140 |
Why?
|
| Isometric Contraction | 2 | 2008 | 150 | 0.140 |
Why?
|
| England | 1 | 2018 | 526 | 0.140 |
Why?
|
| Point-of-Care Systems | 4 | 2015 | 1213 | 0.140 |
Why?
|
| Drug-Seeking Behavior | 1 | 2017 | 46 | 0.140 |
Why?
|
| Rural Health | 1 | 2018 | 296 | 0.140 |
Why?
|
| Vitamin D | 2 | 2021 | 3303 | 0.140 |
Why?
|
| Thrombosis | 1 | 2011 | 2942 | 0.140 |
Why?
|
| Platelet Count | 1 | 2019 | 781 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2019 | 299 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 3 | 2018 | 1702 | 0.140 |
Why?
|
| Risk | 7 | 2016 | 9610 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13642 | 0.140 |
Why?
|
| Prescription Drugs | 1 | 2024 | 631 | 0.140 |
Why?
|
| Resistance Training | 1 | 2018 | 193 | 0.130 |
Why?
|
| Depressive Disorder | 1 | 2009 | 3728 | 0.130 |
Why?
|
| Health Care Reform | 2 | 2015 | 1247 | 0.130 |
Why?
|
| Delivery of Health Care | 4 | 2018 | 5336 | 0.130 |
Why?
|
| Videodisc Recording | 1 | 2015 | 14 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2017 | 5247 | 0.130 |
Why?
|
| Comprehensive Health Care | 1 | 2016 | 123 | 0.130 |
Why?
|
| Computer Peripherals | 2 | 2013 | 38 | 0.130 |
Why?
|
| Social Participation | 1 | 2017 | 183 | 0.130 |
Why?
|
| Absenteeism | 1 | 2017 | 247 | 0.130 |
Why?
|
| Specialization | 2 | 2015 | 778 | 0.130 |
Why?
|
| Job Satisfaction | 1 | 2019 | 544 | 0.130 |
Why?
|
| Private Sector | 2 | 2015 | 398 | 0.130 |
Why?
|
| Waist Circumference | 1 | 2019 | 935 | 0.130 |
Why?
|
| Occupational Exposure | 3 | 2012 | 1813 | 0.120 |
Why?
|
| Naproxen | 1 | 2015 | 100 | 0.120 |
Why?
|
| Diagnostic Services | 1 | 2014 | 34 | 0.120 |
Why?
|
| Health Education | 1 | 2002 | 1052 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 621 | 0.120 |
Why?
|
| Disabled Children | 1 | 2017 | 251 | 0.120 |
Why?
|
| Occupational Health Services | 1 | 2016 | 150 | 0.120 |
Why?
|
| Emergency Service, Hospital | 6 | 2013 | 7879 | 0.120 |
Why?
|
| Leadership | 3 | 2024 | 1385 | 0.120 |
Why?
|
| Internationality | 1 | 2020 | 1001 | 0.120 |
Why?
|
| Running | 1 | 2019 | 488 | 0.120 |
Why?
|
| Cross-Over Studies | 3 | 2016 | 2079 | 0.120 |
Why?
|
| Financing, Personal | 2 | 2014 | 309 | 0.120 |
Why?
|
| Risk Reduction Behavior | 2 | 2019 | 1112 | 0.120 |
Why?
|
| Proprioception | 1 | 2015 | 133 | 0.120 |
Why?
|
| Models, Biological | 5 | 2020 | 9469 | 0.120 |
Why?
|
| Nonprescription Drugs | 1 | 2015 | 118 | 0.120 |
Why?
|
| Physicians' Offices | 1 | 2014 | 60 | 0.120 |
Why?
|
| Wrist Joint | 2 | 2014 | 267 | 0.120 |
Why?
|
| Patellofemoral Joint | 1 | 2016 | 133 | 0.120 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 2164 | 0.120 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2018 | 452 | 0.110 |
Why?
|
| Nutrition Surveys | 2 | 2012 | 1733 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2015 | 229 | 0.110 |
Why?
|
| Databases as Topic | 3 | 2011 | 473 | 0.110 |
Why?
|
| Monte Carlo Method | 2 | 2019 | 1258 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2007 | 2781 | 0.110 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 426 | 0.110 |
Why?
|
| Anticipation, Psychological | 1 | 2014 | 85 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 495 | 0.110 |
Why?
|
| Length of Stay | 4 | 2010 | 6426 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 1924 | 0.110 |
Why?
|
| Veterans | 2 | 2021 | 2649 | 0.110 |
Why?
|
| Biological Factors | 1 | 2014 | 157 | 0.110 |
Why?
|
| Random Allocation | 2 | 2017 | 2395 | 0.110 |
Why?
|
| Palliative Care | 1 | 2008 | 3598 | 0.110 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2015 | 423 | 0.110 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
| Cross-Cultural Comparison | 1 | 2016 | 635 | 0.100 |
Why?
|
| Religion | 1 | 2016 | 372 | 0.100 |
Why?
|
| Insect Hormones | 1 | 2012 | 73 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2016 | 2020 | 0.100 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2012 | 65 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 3769 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2019 | 1315 | 0.100 |
Why?
|
| Video Recording | 2 | 2017 | 967 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2017 | 765 | 0.100 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 3889 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 2 | 2009 | 1036 | 0.100 |
Why?
|
| United States Food and Drug Administration | 2 | 2018 | 1664 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21017 | 0.100 |
Why?
|
| Hearing Disorders | 1 | 2012 | 126 | 0.100 |
Why?
|
| Vitamins | 1 | 2020 | 1635 | 0.100 |
Why?
|
| Hip | 1 | 2013 | 255 | 0.100 |
Why?
|
| Restaurants | 1 | 2014 | 231 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2008 | 4352 | 0.100 |
Why?
|
| Prostheses and Implants | 2 | 2013 | 1271 | 0.100 |
Why?
|
| Geography | 4 | 2019 | 656 | 0.100 |
Why?
|
| Tendinopathy | 1 | 2014 | 173 | 0.100 |
Why?
|
| Regional Health Planning | 2 | 2015 | 96 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 1036 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1779 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 909 | 0.100 |
Why?
|
| Education, Medical, Continuing | 3 | 2005 | 823 | 0.100 |
Why?
|
| Drug Approval | 1 | 2018 | 814 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2015 | 662 | 0.090 |
Why?
|
| Labor Unions | 2 | 2015 | 49 | 0.090 |
Why?
|
| Ontario | 3 | 2018 | 398 | 0.090 |
Why?
|
| Odontoid Process | 1 | 2011 | 46 | 0.090 |
Why?
|
| Remission Induction | 2 | 2015 | 2397 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2015 | 1897 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2022 | 2036 | 0.090 |
Why?
|
| Dietary Supplements | 2 | 2021 | 3415 | 0.090 |
Why?
|
| Urban Health Services | 1 | 2012 | 177 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2019 | 1376 | 0.090 |
Why?
|
| Cartilage | 1 | 2014 | 806 | 0.090 |
Why?
|
| Survival Analysis | 3 | 2010 | 10090 | 0.090 |
Why?
|
| Poverty | 3 | 2014 | 2698 | 0.090 |
Why?
|
| Cardiovascular Diseases | 4 | 2012 | 15501 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 2064 | 0.090 |
Why?
|
| Cost Sharing | 1 | 2014 | 409 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 532 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2016 | 2571 | 0.090 |
Why?
|
| Lymphoma | 1 | 2019 | 1901 | 0.090 |
Why?
|
| North Carolina | 2 | 2024 | 325 | 0.090 |
Why?
|
| Self-Help Devices | 1 | 2010 | 62 | 0.090 |
Why?
|
| Tendon Injuries | 1 | 2014 | 328 | 0.090 |
Why?
|
| Environment, Controlled | 2 | 2007 | 42 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 1624 | 0.090 |
Why?
|
| Treatment Refusal | 2 | 2011 | 429 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2020 | 42230 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1505 | 0.090 |
Why?
|
| Information Seeking Behavior | 1 | 2011 | 116 | 0.090 |
Why?
|
| Device Approval | 1 | 2011 | 163 | 0.080 |
Why?
|
| Movement | 3 | 2013 | 1479 | 0.080 |
Why?
|
| Fecal Incontinence | 1 | 2012 | 241 | 0.080 |
Why?
|
| Cultural Characteristics | 1 | 2011 | 251 | 0.080 |
Why?
|
| Assisted Living Facilities | 1 | 2009 | 27 | 0.080 |
Why?
|
| Biological Products | 1 | 2018 | 914 | 0.080 |
Why?
|
| Uganda | 3 | 2018 | 1332 | 0.080 |
Why?
|
| Empirical Research | 1 | 2009 | 120 | 0.080 |
Why?
|
| Nerve Compression Syndromes | 1 | 2011 | 160 | 0.080 |
Why?
|
| Emotions | 1 | 2021 | 2739 | 0.080 |
Why?
|
| Diphosphonates | 2 | 2011 | 635 | 0.080 |
Why?
|
| Joint Instability | 1 | 2016 | 801 | 0.080 |
Why?
|
| Sclerosis | 1 | 2009 | 210 | 0.080 |
Why?
|
| Cities | 1 | 2011 | 546 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2016 | 1222 | 0.080 |
Why?
|
| Vitamin K | 1 | 2011 | 318 | 0.080 |
Why?
|
| Germany, West | 1 | 2008 | 13 | 0.080 |
Why?
|
| Germany, East | 1 | 2008 | 6 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4915 | 0.080 |
Why?
|
| Office Visits | 2 | 2009 | 595 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2016 | 1914 | 0.080 |
Why?
|
| Automobiles | 1 | 2009 | 111 | 0.080 |
Why?
|
| Urinary Incontinence | 1 | 2012 | 489 | 0.070 |
Why?
|
| Rural Health Services | 1 | 2012 | 384 | 0.070 |
Why?
|
| Hand Deformities, Acquired | 1 | 2008 | 36 | 0.070 |
Why?
|
| Bone Marrow | 3 | 2016 | 2911 | 0.070 |
Why?
|
| Gastrectomy | 2 | 2023 | 672 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 791 | 0.070 |
Why?
|
| Postural Balance | 1 | 2012 | 622 | 0.070 |
Why?
|
| Infant | 4 | 2020 | 36192 | 0.070 |
Why?
|
| Learning | 1 | 2017 | 1740 | 0.070 |
Why?
|
| Fatigue | 1 | 2015 | 1552 | 0.070 |
Why?
|
| Insurance Claim Review | 2 | 2010 | 741 | 0.070 |
Why?
|
| Child | 8 | 2023 | 80156 | 0.070 |
Why?
|
| Bone Density | 5 | 2008 | 3551 | 0.070 |
Why?
|
| Fibrosis | 3 | 2019 | 2049 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 367 | 0.070 |
Why?
|
| Syndrome | 2 | 2010 | 3267 | 0.070 |
Why?
|
| Femur Head Necrosis | 2 | 2009 | 132 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2008 | 257 | 0.070 |
Why?
|
| Small Business | 2 | 2017 | 9 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2008 | 239 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2012 | 1187 | 0.070 |
Why?
|
| Soccer | 1 | 2009 | 142 | 0.070 |
Why?
|
| Benchmarking | 1 | 2013 | 1045 | 0.070 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2009 | 224 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4811 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1403 | 0.070 |
Why?
|
| Income | 2 | 2013 | 1877 | 0.070 |
Why?
|
| Health Facility Size | 1 | 2006 | 61 | 0.070 |
Why?
|
| Fee-for-Service Plans | 1 | 2012 | 700 | 0.070 |
Why?
|
| Vertebroplasty | 1 | 2007 | 78 | 0.070 |
Why?
|
| Administration, Oral | 4 | 2011 | 4021 | 0.070 |
Why?
|
| Topography, Medical | 1 | 2006 | 37 | 0.070 |
Why?
|
| Hand Strength | 1 | 2009 | 456 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2012 | 1784 | 0.070 |
Why?
|
| Regression Analysis | 6 | 2015 | 6344 | 0.070 |
Why?
|
| Insurance, Health | 2 | 2015 | 2498 | 0.070 |
Why?
|
| Rehabilitation | 1 | 2007 | 130 | 0.060 |
Why?
|
| Epidemiologic Studies | 1 | 2009 | 675 | 0.060 |
Why?
|
| Texas | 1 | 2007 | 404 | 0.060 |
Why?
|
| Hospitals, Urban | 3 | 2012 | 500 | 0.060 |
Why?
|
| HIV | 1 | 2013 | 1582 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2007 | 350 | 0.060 |
Why?
|
| Immune System | 1 | 2011 | 796 | 0.060 |
Why?
|
| Fingers | 1 | 2008 | 507 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2015 | 6845 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6312 | 0.060 |
Why?
|
| Recurrence | 2 | 2012 | 8466 | 0.060 |
Why?
|
| Social Support | 1 | 2015 | 2171 | 0.060 |
Why?
|
| Muscle Contraction | 2 | 2008 | 1201 | 0.060 |
Why?
|
| Air Microbiology | 1 | 2005 | 95 | 0.060 |
Why?
|
| Work Capacity Evaluation | 1 | 2005 | 44 | 0.060 |
Why?
|
| Drug and Narcotic Control | 1 | 2006 | 144 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2012 | 1199 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1088 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6391 | 0.060 |
Why?
|
| Shoulder | 3 | 2014 | 300 | 0.060 |
Why?
|
| Teaching Materials | 1 | 2005 | 84 | 0.060 |
Why?
|
| Device Removal | 1 | 2010 | 630 | 0.060 |
Why?
|
| Cost Savings | 2 | 2023 | 913 | 0.060 |
Why?
|
| Frail Elderly | 1 | 2010 | 765 | 0.060 |
Why?
|
| Neonatal Screening | 1 | 2009 | 597 | 0.060 |
Why?
|
| Handwriting | 1 | 2004 | 26 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2011 | 995 | 0.060 |
Why?
|
| Colorado | 1 | 2004 | 165 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2019 | 3416 | 0.060 |
Why?
|
| Prednisone | 2 | 2006 | 1563 | 0.060 |
Why?
|
| Prosthesis-Related Infections | 1 | 2010 | 487 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6484 | 0.060 |
Why?
|
| Population | 1 | 2004 | 141 | 0.060 |
Why?
|
| California | 2 | 2024 | 1430 | 0.060 |
Why?
|
| Telemedicine | 1 | 2022 | 3052 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2010 | 735 | 0.060 |
Why?
|
| Life Style | 2 | 2017 | 3917 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 2 | 2013 | 1784 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 321 | 0.060 |
Why?
|
| Postal Service | 1 | 2004 | 96 | 0.060 |
Why?
|
| Lactones | 1 | 2006 | 317 | 0.060 |
Why?
|
| Pressure | 1 | 2007 | 1154 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4319 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 2529 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2016 | 2017 | 0.050 |
Why?
|
| Sulfones | 1 | 2006 | 448 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2012 | 1819 | 0.050 |
Why?
|
| Emergency Medical Services | 2 | 2012 | 1923 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2015 | 1940 | 0.050 |
Why?
|
| Urban Population | 2 | 2012 | 2036 | 0.050 |
Why?
|
| Calcitonin | 3 | 2010 | 329 | 0.050 |
Why?
|
| Pyridoxine | 1 | 2003 | 108 | 0.050 |
Why?
|
| Bone Screws | 1 | 2006 | 532 | 0.050 |
Why?
|
| Lost to Follow-Up | 2 | 2014 | 123 | 0.050 |
Why?
|
| Hospitals, General | 1 | 2007 | 798 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1182 | 0.050 |
Why?
|
| Sputum | 2 | 2016 | 506 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 925 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2010 | 834 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 2491 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 1462 | 0.050 |
Why?
|
| Public Opinion | 1 | 2006 | 484 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 2006 | 443 | 0.050 |
Why?
|
| New Hampshire | 1 | 2002 | 175 | 0.050 |
Why?
|
| Interior Design and Furnishings | 1 | 2002 | 34 | 0.050 |
Why?
|
| Health Facilities, Proprietary | 1 | 2021 | 37 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2850 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2011 | 1545 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3359 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 5146 | 0.050 |
Why?
|
| Splints | 1 | 2002 | 108 | 0.050 |
Why?
|
| Calcinosis | 1 | 2010 | 1469 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8481 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 2084 | 0.050 |
Why?
|
| Prescriptions | 1 | 2024 | 386 | 0.050 |
Why?
|
| Forecasting | 4 | 2014 | 2928 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 710 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2019 | 26198 | 0.040 |
Why?
|
| Rupture | 1 | 2022 | 443 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2024 | 485 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2007 | 789 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 1668 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 289 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 4369 | 0.040 |
Why?
|
| Inpatients | 2 | 2020 | 2548 | 0.040 |
Why?
|
| Diuretics | 1 | 2003 | 610 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2011 | 2072 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 1336 | 0.040 |
Why?
|
| Heat Stroke | 1 | 2019 | 29 | 0.040 |
Why?
|
| Hospital Mortality | 2 | 2005 | 5293 | 0.040 |
Why?
|
| Maine | 1 | 2019 | 147 | 0.040 |
Why?
|
| Patients | 1 | 2006 | 907 | 0.040 |
Why?
|
| Hip Contracture | 1 | 2019 | 3 | 0.040 |
Why?
|
| Tibia | 2 | 2015 | 1070 | 0.040 |
Why?
|
| Blister | 1 | 2019 | 86 | 0.040 |
Why?
|
| Organizations | 1 | 2020 | 171 | 0.040 |
Why?
|
| Population Groups | 1 | 2020 | 208 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2091 | 0.040 |
Why?
|
| Neck | 2 | 2014 | 734 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2011 | 5079 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2007 | 1391 | 0.040 |
Why?
|
| Community Health Services | 1 | 2024 | 656 | 0.040 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2019 | 109 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2011 | 3905 | 0.040 |
Why?
|
| Education | 1 | 2002 | 537 | 0.040 |
Why?
|
| New England | 1 | 2002 | 1054 | 0.040 |
Why?
|
| Pelvis | 1 | 2023 | 733 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2020 | 204 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 793 | 0.040 |
Why?
|
| Weather | 1 | 2019 | 231 | 0.040 |
Why?
|
| Gait | 1 | 2024 | 814 | 0.040 |
Why?
|
| Infection Control | 1 | 2005 | 982 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 12975 | 0.040 |
Why?
|
| Vasculitis | 1 | 2002 | 521 | 0.040 |
Why?
|
| Medicine | 2 | 2021 | 942 | 0.040 |
Why?
|
| Head | 2 | 2014 | 924 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 260 | 0.040 |
Why?
|
| Etidronic Acid | 2 | 2008 | 63 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 928 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2012 | 4527 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2019 | 188 | 0.040 |
Why?
|
| Professional Role | 1 | 2020 | 314 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2017 | 70 | 0.040 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 156 | 0.030 |
Why?
|
| Sepsis | 1 | 2011 | 2585 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2009 | 5972 | 0.030 |
Why?
|
| Probability | 1 | 2002 | 2477 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2002 | 870 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2003 | 947 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4853 | 0.030 |
Why?
|
| Alendronate | 2 | 2008 | 175 | 0.030 |
Why?
|
| Biomedical Technology | 1 | 2018 | 211 | 0.030 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2016 | 41 | 0.030 |
Why?
|
| Specialties, Surgical | 1 | 2021 | 389 | 0.030 |
Why?
|
| Electromyography | 2 | 2013 | 1394 | 0.030 |
Why?
|
| Risk-Taking | 2 | 2011 | 1038 | 0.030 |
Why?
|
| New Jersey | 2 | 2008 | 295 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 539 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 4544 | 0.030 |
Why?
|
| Narration | 1 | 2017 | 219 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2015 | 303 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 936 | 0.030 |
Why?
|
| Informed Consent | 2 | 2011 | 1008 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2020 | 836 | 0.030 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 2024 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2015 | 209 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1139 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2020 | 12341 | 0.030 |
Why?
|
| Rotation | 1 | 2016 | 517 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 709 | 0.030 |
Why?
|
| Utilization Review | 2 | 2007 | 382 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4176 | 0.030 |
Why?
|
| Systems Integration | 1 | 2015 | 426 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 2014 | 248 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2019 | 1440 | 0.030 |
Why?
|
| International Cooperation | 2 | 2011 | 1422 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6403 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2017 | 857 | 0.030 |
Why?
|
| Continuity of Patient Care | 2 | 2010 | 1069 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2007 | 5914 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2019 | 2707 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10766 | 0.030 |
Why?
|
| Radiology | 1 | 2006 | 2113 | 0.030 |
Why?
|
| Population Surveillance | 2 | 2015 | 2598 | 0.020 |
Why?
|
| Automation | 1 | 2014 | 586 | 0.020 |
Why?
|
| Clinical Coding | 1 | 2013 | 181 | 0.020 |
Why?
|
| Resistin | 1 | 2012 | 172 | 0.020 |
Why?
|
| Narcotics | 1 | 2014 | 336 | 0.020 |
Why?
|
| Statistics as Topic | 2 | 2009 | 2358 | 0.020 |
Why?
|
| Urinalysis | 1 | 2014 | 368 | 0.020 |
Why?
|
| General Surgery | 1 | 2003 | 1692 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8528 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1200 | 0.020 |
Why?
|
| Atlanto-Axial Joint | 1 | 2011 | 60 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2010 | 22 | 0.020 |
Why?
|
| Methotrexate | 2 | 2008 | 1719 | 0.020 |
Why?
|
| Bone Cements | 1 | 2012 | 325 | 0.020 |
Why?
|
| Hospitals, Rural | 1 | 2012 | 176 | 0.020 |
Why?
|
| Somatosensory Disorders | 1 | 2010 | 49 | 0.020 |
Why?
|
| Stereotyping | 1 | 2012 | 239 | 0.020 |
Why?
|
| Postmenopause | 2 | 2014 | 2513 | 0.020 |
Why?
|
| Wheelchairs | 1 | 2010 | 78 | 0.020 |
Why?
|
| Wrist | 1 | 2012 | 227 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 9177 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2019 | 1796 | 0.020 |
Why?
|
| Commerce | 1 | 2015 | 606 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2014 | 617 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2010 | 150 | 0.020 |
Why?
|
| Osteotomy | 1 | 2015 | 837 | 0.020 |
Why?
|
| Ethics, Research | 1 | 2011 | 176 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 224 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2011 | 517 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2010 | 117 | 0.020 |
Why?
|
| Femur | 1 | 2015 | 1307 | 0.020 |
Why?
|
| Ulna Fractures | 1 | 2010 | 126 | 0.020 |
Why?
|
| Sensation | 1 | 2011 | 337 | 0.020 |
Why?
|
| Reflex | 1 | 2011 | 376 | 0.020 |
Why?
|
| Immobilization | 1 | 2010 | 229 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1835 | 0.020 |
Why?
|
| Colombia | 1 | 2009 | 282 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2468 | 0.020 |
Why?
|
| ROC Curve | 1 | 2016 | 3579 | 0.020 |
Why?
|
| Prejudice | 1 | 2012 | 570 | 0.020 |
Why?
|
| Forearm | 1 | 2011 | 427 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2010 | 285 | 0.020 |
Why?
|
| Humerus | 1 | 2010 | 272 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2009 | 249 | 0.020 |
Why?
|
| Saliva | 1 | 2012 | 828 | 0.020 |
Why?
|
| Joint Deformities, Acquired | 1 | 2008 | 35 | 0.020 |
Why?
|
| HIV-2 | 1 | 2008 | 156 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 935 | 0.020 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2008 | 52 | 0.020 |
Why?
|
| Decision Trees | 1 | 2009 | 504 | 0.020 |
Why?
|
| Medicaid | 2 | 2015 | 2818 | 0.020 |
Why?
|
| Elbow Joint | 1 | 2011 | 359 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1886 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2011 | 947 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 959 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2134 | 0.020 |
Why?
|
| Body Height | 1 | 2012 | 1570 | 0.020 |
Why?
|
| Switzerland | 1 | 2006 | 324 | 0.020 |
Why?
|
| Health Educators | 1 | 2005 | 19 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2012 | 1303 | 0.020 |
Why?
|
| Internal Fixators | 1 | 2006 | 183 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2005 | 103 | 0.020 |
Why?
|
| Computers, Handheld | 1 | 2007 | 210 | 0.020 |
Why?
|
| Medical Assistance | 1 | 2005 | 108 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 1157 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3271 | 0.020 |
Why?
|
| Pharmacoepidemiology | 1 | 2008 | 350 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2011 | 1047 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 585 | 0.010 |
Why?
|
| Morbidity | 1 | 2010 | 1750 | 0.010 |
Why?
|
| Nurses | 1 | 2014 | 2478 | 0.010 |
Why?
|
| Radius Fractures | 1 | 2010 | 515 | 0.010 |
Why?
|
| Densitometry | 1 | 2004 | 151 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2014 | 1978 | 0.010 |
Why?
|
| Heart Failure | 1 | 2008 | 11670 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2008 | 638 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2014 | 2009 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 2008 | 306 | 0.010 |
Why?
|
| Polypharmacy | 1 | 2005 | 306 | 0.010 |
Why?
|
| Medical Audit | 1 | 2004 | 453 | 0.010 |
Why?
|
| Sweden | 1 | 2006 | 1379 | 0.010 |
Why?
|
| Rural Population | 1 | 2012 | 2285 | 0.010 |
Why?
|
| Body Weight | 1 | 2012 | 4618 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8656 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 2177 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2330 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2011 | 2180 | 0.010 |
Why?
|
| Australia | 1 | 2004 | 1250 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 1080 | 0.010 |
Why?
|
| Professional Practice | 1 | 2002 | 313 | 0.010 |
Why?
|
| Gout | 1 | 2008 | 621 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2003 | 307 | 0.010 |
Why?
|
| Cognition | 1 | 2018 | 6992 | 0.010 |
Why?
|
| Software | 1 | 2014 | 4434 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 1192 | 0.010 |
Why?
|
| Acute Disease | 1 | 2010 | 7237 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2005 | 1188 | 0.010 |
Why?
|
| Gene Expression | 1 | 2011 | 7581 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 22173 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 12794 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6635 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3810 | 0.010 |
Why?
|
| Communication | 1 | 2006 | 3873 | 0.010 |
Why?
|
| HIV-1 | 1 | 2008 | 6863 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11461 | 0.000 |
Why?
|
| Stroke | 1 | 2006 | 9758 | 0.000 |
Why?
|